Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected

Talib DosaniInternal Medicine Department, University Hospitals Seidman Cancer Center, Cleveland, OH, USA;

Fahrettin CovutStem Cell Transplant Program University Hospitals Seidman Cancer Center Case Comprehensive Cancer Center and Case Western Reserve University, Cleveland, OH, USA;

Raisa PintoStem Cell Transplant Program University Hospitals Seidman Cancer Center Case Comprehensive Cancer Center and Case Western Reserve University, Cleveland, OH, USA;

Byung-Gyu KimPediatrics & Angie Fowler AYA Cancer Institute Case Western Reserve University, Cleveland, OH, USA;

Naveed AliStem Cell Transplant Program University Hospitals Seidman Cancer Center Case Comprehensive Cancer Center and Case Western Reserve University, Cleveland, OH, USA;

Rose BeckPathology Department, University Hospitals Cleveland Medical Center, Cleveland, OH, USA;

Robert MaittaPathology Department, University Hospitals Cleveland Medical Center, Cleveland, OH, USA;

Katharine DownesPathology Department, University Hospitals Cleveland Medical Center, Cleveland, OH, USA;

Robert FoxCellular Therapy Lab Case Western Reserve University, Cleveland, OH, USA

Jane ReeseCellular Therapy Lab Case Western Reserve University, Cleveland, OH, USA

Marcos de LimaStem Cell Transplant Program University Hospitals Seidman Cancer Center Case Comprehensive Cancer Center and Case Western Reserve University, Cleveland, OH, USA;

Ehsan MalekStem Cell Transplant Program University Hospitals Seidman Cancer Center Case Comprehensive Cancer Center and Case Western Reserve University, Cleveland, OH, USA; Correspondence[email protected]

show all

Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected

Supplemental Table 1

Supplementary Figure 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected

Supplemental Table 1

Supplementary Figure 1

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date